<DOC>
	<DOCNO>NCT01164033</DOCNO>
	<brief_summary>This open-label , randomize , cross-over study evaluate effect food pharmacokinetics single oral dos RO5045337 patient solid tumor . The anticipated time study treatment 3 week .</brief_summary>
	<brief_title>A Study RO5045337 Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Adult patient , &gt; /=18 year age Histologically confirm solid tumor Life expectancy &gt; /=12 week ECOG performance status 0 1 Adequate bone marrow , renal hepatic function Patients receive investigational agent therapy administer intention treat malignancy within 28 day prior study start Patients preexist gastrointestinal disorder Patients uncontrolled intercurrent illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>